Medical Developments International (MDI)
Maria Dimopoulos has extensive experience in business development within the pharmaceutical industry. Currently serving as a Business Development Manager at Medical Developments International since November 2021, Maria previously held similar roles at Arrow Pharmaceuticals from April 2018 to February 2022 and at Juno Pharmaceuticals Pty Ltd as a Portfolio Development Manager from January 2016 to March 2018. This cumulative experience showcases a strong background in strategic planning and market expansion in the healthcare sector.
Medical Developments International (MDI)
"Delivering emergency medical solutions dedicated to improving patient outcomes" Medical Developments International (MDI) is one of Australia’s leading specialised healthcare companies. With an industry leading range of products in the areas of pain management, asthma and resuscitation, plus veterinary equipment, MDI has supplied healthcare professionals and patients innovative solutions since 1971. MDI is a publicly listed company on the Australian Stock Exchange (ASX) with both its head office and state of the art manufacturing facilities located in Victoria, Australia. MDI manufacture the innovative pain relief product, Penthrox® that has been widely adopted by organisations throughout Australia. MDI has a proud history in human and veterinary medicine, throughout Australia as well as internationally. For over 30 years MDI's key products have helped healthcare professionals achieve better health outcomes for their patients MDI is compliant with Good Manufacturing Practices as well as ISO 13485 for the manufacture of several of its products (including both pharmaceutical and medical products). Several MDI products are also CE marked, enabling them to be sold into the European Community.